SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics
LXRX 1.250-12.6%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (20)11/27/2000 8:03:21 PM
From: Toby Zidle   of 254
 
I do appreciate the abundance of positive press releases that have been posted in recent weeks. I am trying to reconcile this strong outlook on paper with the horrendous outlook I see when I look at the LEXG chart.

Barcharts.com now rates LEXG an overall 80% 'Sell'. Further, not a single technical indicator, of 13 presented on that site, calls LEXG a 'Buy'. quotes.barchart.com

I suppose that means that the T.A.-oriented investors will just sit on the sideline watching the price continue to trend down until something is found that will turn the stock around.

IBD rates LEXG a "C" in Accumulation/Distribution (neutral) within an "A"-rated industry. Relative Price Strength for LEXG is an anemic '31'.

Where's the good entry point on this stock? Back at the $9 - $10 Lows of early summer?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext